PCN42 COST EFFECTIVENESS OF FULVESTRANT AS AN ADDITIONAL ENDOCRINE STEP IN THE TREATMENT SEQUENCE FOR HORMONE RESPONSIVE ADVANCED BREAST CANCER

Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63472-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)63472-9/fulltext
Title : PCN42 COST EFFECTIVENESS OF FULVESTRANT AS AN ADDITIONAL ENDOCRINE STEP IN THE TREATMENT SEQUENCE FOR HORMONE RESPONSIVE ADVANCED BREAST CANCER
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63472-9&doi=10.1016/S1098-3015(10)63472-9
First page :
Section Title :
Open access? : No
Section Order : 323
Categories :
Tags :
Regions :
ViH Article Tags :